Add BrightSurf on Google Email

Science News for April 15, 2003


JCI Table of Contents, April 15, 2003

Researchers investigate targeting pericytes and endothelial cells with kinase inhibitors to treat cancer and autoimmune diseases. PDX1 levels also play a crucial role in islet survival and diabetes development, while Factor H's anti-inflammatory properties are explored for hemolytic uremic syndrome treatment.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateApr 15, 2003

Study reveals staph infection risk

A study published in the Journal of Infectious Diseases found that people undergoing hemodialysis are 257 times more likely to contract Staphylococcus aureus (ISA) than the general population. Those with HIV, solid organ transplant recipients, and heart disease patients are also at increased risk.

SourceMichigan State University·JournalThe Journal of Infectious Diseases·DateApr 15, 2003

Common thyroid cancer gene mutation found

Researchers at Johns Hopkins Medicine discovered a BRAF gene mutation in 68% of papillary thyroid cancers, which can be challenging to distinguish from benign conditions. This mutation causes continuous cell growth and division, leading to cancer.

SourceJohns Hopkins Medicine·JournalJNCI Journal of the National Cancer Institute·DateApr 15, 2003

Increased heart mortality rates linked to lower state subsidies of uninsured in New Jersey

A study by University of Pennsylvania researchers found that a shift from rate-setting to market-based competition in New Jersey's healthcare system led to increased mortality rates among uninsured patients with acute myocardial infarctions. Mortality rates for insured patients declined at the same rate in both states.

SourceUniversity of Pennsylvania School of Medicine·JournalHealth Services Research·DateApr 15, 2003

Other highlights of the April 16 JNCI

A study published in the Journal of the National Cancer Institute found that only 40% of patients with superficial bladder cancer had regular follow-up examinations, despite recommended guidelines. Patient characteristics such as age, ethnicity, and socioeconomic status were independently associated with low-intensity surveillance.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateApr 15, 2003

Estrogen patch compared to pill minimizes cardiovascular risk factor in postmenopausal women

A recent study published in the Journal of the American College of Cardiology found that oral estrogen therapy increased C-reactive protein (CRP) levels, while transdermal estrogen therapy had no effect. The researchers suggest that the route of administration may be a crucial factor in minimizing cardiovascular risks associated with e...

SourceUT Southwestern Medical Center·JournalJournal of the American College of Cardiology·DateApr 15, 2003